It was confirmed that the expression of 60 genes among 91 IL-17 signaling pathway-related genes for which expression data were available increased the infiltration of CD8+ T cells in breast cancer, while the expression of eight genes (including IL25) showed a weakly negative correlation with CD8+ T cell infiltration. This evidence concerns the gene IL17A and breast carcinoma.